Incidence and determinants of spontaneous cardioversion of early onset symptomatic atrial fibrillation
MV Mariani, N Pierucci, A Piro, S Trivigno, C Chimenti… - Medicina, 2022 - mdpi.com
Atrial fibrillation (AF) is the most frequent chronic arrhythmia worldwide, and it is associated
with significant morbidity and mortality, making it a considerable burden both to patients and …
with significant morbidity and mortality, making it a considerable burden both to patients and …
Finding low CHA2DS2-VASc scores unreliable? Why not give morphological and hemodynamic methods a try?
YR Sun, Y Ling, Z Chen, Z Wang, T Li… - Frontiers in …, 2023 - frontiersin.org
Patients with atrial fibrillation (AF) suffer from a high risk of thrombosis. Currently, the
CHA2DS2-VASc score is the most widely used tool for risk stratification in patients with AF …
CHA2DS2-VASc score is the most widely used tool for risk stratification in patients with AF …
Rates of intracranial hemorrhage in mild head trauma patients presenting to emergency department and their management: a comparison of direct oral anticoagulant …
G Savioli, IF Ceresa, S Luzzi, C Gragnaniello… - Medicina, 2020 - mdpi.com
Background and objectives: Anticoagulants are thought to increase the risks of traumatic
intracranial injury and poor clinical outcomes after blunt head trauma. The safety of using …
intracranial injury and poor clinical outcomes after blunt head trauma. The safety of using …
Clinical, economic, and humanistic impact of a multidisciplinary medication review with follow-up for anticoagulated patients treated with vitamin K antagonists in …
A Sáez-Benito, N Berenguer, R Magallón… - Research in Social and …, 2023 - Elsevier
Background Interdisciplinary collaboration between general practitioner, nurses and
pharmacists can favour the control of patients treated with vitamin K antagonists (VKA) …
pharmacists can favour the control of patients treated with vitamin K antagonists (VKA) …
Paul Owren, Christopher Bjerkelund and the dawn of controlled trials in Norway
M Nylenna - Journal of the Royal Society of Medicine, 2024 - journals.sagepub.com
In 1943, during the German occupation of Norway, a 29-year-old woman was admitted to
Medical Department A at The National Hospital (Rikshospitalet) in Oslo. She would become …
Medical Department A at The National Hospital (Rikshospitalet) in Oslo. She would become …
Mild Head Trauma (MHT) and Antiplatelet Therapy. Reply to Lorenzati et al. Comment on “Savioli et al. Mild Head Trauma: Is Antiplatelet Therapy a Risk Factor for …
G Savioli, IF Ceresa, S Luzzi, A Giotta Lucifero… - Medicina, 2021 - mdpi.com
Medicina | Free Full-Text | Mild Head Trauma (MHT) and Antiplatelet Therapy. Reply to
Lorenzati et al. Comment on “Savioli et al. Mild Head Trauma: Is Antiplatelet Therapy a Risk …
Lorenzati et al. Comment on “Savioli et al. Mild Head Trauma: Is Antiplatelet Therapy a Risk …
[HTML][HTML] Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants
M Metze, C Pfrepper, T Klöter, S Stöbe… - Research and Practice …, 2020 - Elsevier
Background The residual antithrombotic activity 12 hours after intake of direct oral
anticoagulants (DOACs) is of clinical relevance in the setting of bleeding or urgent surgery …
anticoagulants (DOACs) is of clinical relevance in the setting of bleeding or urgent surgery …
ORal anticoagulation risks late aortic intervention in Conservatively managed type B Aortic dissection (ORCA study)
K Jesse, L Meuli, R Kopp, B Reutersberg… - European Journal of …, 2022 - academic.oup.com
OBJECTIVES Single-center retrospective cohort study to evaluate the impact of oral
anticoagulation (OAC) on long-term outcomes of conservatively managed acute type B …
anticoagulation (OAC) on long-term outcomes of conservatively managed acute type B …
Pharmacokinetics of phenprocoumon in emergency situations–results of the prospective observational RADOA-registry (reversal agent use in patients treated with …
E Lindhoff-Last, I Birschmann, AJ Bidenharn, J Kuhn… - Pharmaceuticals, 2022 - mdpi.com
Background: Phenprocoumon has been used as an oral anticoagulant in patients with
thromboembolic disease for more than 40 years. So far its pharmacokinetics have not been …
thromboembolic disease for more than 40 years. So far its pharmacokinetics have not been …
Apixaban plasma concentrations in patients with obesity
F Al-Aieshy, M Skeppholm, J Fyrestam… - European Journal of …, 2024 - Springer
Purpose Routine therapeutic drug monitoring of apixaban is currently not recommended but
may however be warranted in some situations and for some patient groups to provide better …
may however be warranted in some situations and for some patient groups to provide better …